Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Fatty Acids
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Fatty Acids

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 3 min read

Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (545 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (fatty acids, unsaturated). (Grant and Hackh's Chemical Dictionary, 5th ed)

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Fatty Acid; Aliphatic Acids; Aliphatic Acid; Acid, Aliphatic; Fatty Acids, Esterified; Esterified Fatty Acids; Esterified Fatty Acid; Acid, Esterified Fatty.

Where it fits in the MeSH classification

Broader topics
Lipids
Narrower topics
Caprylates; Decanoic Acids; Eicosanoic Acids; Endocannabinoids; Fatty Acids, Nonesterified; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Heptanoic Acids; Lauric Acids; Mupirocin; Mycolic Acids; Mycophenolic Acid; Myristic Acids; Palmitic Acids

Related concepts

  • Fatty Acids
  • Unsaturated

Research landscape

PubMed indexes 535,446 records tagged with the MeSH heading “Fatty Acids” (counts retrieved 2026-10-31). 81,142 of them (15.2%) were published from 2020 onward, and the busiest period so far is through 1999 with 219,082 records.

Reviews account for 43,898 records (8.2%) and meta-analyses for 2,538. Randomized controlled trials number 21,062 (3.9%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 219,082 records; 2000-2009: 106,843 records; 2010-2019: 128,379 records; 2020 onward: 81,142 records219,082through 1999106,8432000-2009128,3792010-201981,1422020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999219,082
2000-2009106,843
2010-2019128,379
2020 onward81,142
Share of records by publication typeReviews: 8.2 percent; Meta-analyses: 0.5 percent; Randomized controlled trials: 3.9 percentReviews8.2% (43,898)Meta-analyses0.5% (2,538)Randomized controlled trials3.9% (21,062)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 535,446 PubMed records
TypeRecordsShare
Reviews43,8988.2%
Meta-analyses2,5380.5%
Randomized controlled trials21,0623.9%

Method: PubMed query "Fatty Acids"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
The HMG-CoA Reductase Inhibitor Fluvastatin Promotes Th2-Skewed Immune Responses by Modulating Dendritic Cell Differentiation
Ishikawa S, Mizuno H, Murase K, Sasano K, Ogawa I, Itoh Y, et al.
2026Research article
Design not recorded in structured metadata
1cc by
PMID 42680200 · DOI · PMC13533597
Palmitate promotes liver metastases by decreasing neutrophil antitumour behaviour
Vandekeere A, Fernández-García J, Peng-Winkler Y, Martín Pérez M, Liu M, Fernandes SI, et al.
2026Research article
Design not recorded in structured metadata
1cc by
PMID 42557388 · DOI · PMC7619559
Effects of Prepartum Supplementation with Flaxseed and Black Soldier Fly Larvae Oils on Fatty Acid Composition and Lipid Quality Indices in Sheep Milk
Lewandowska K, Pachura-Hanusek N, Szumny A, Zielak-Steciwko A, Kupczyński R
2026Research article
Design not recorded in structured metadata
1cc by
PMID 42588476 · DOI · PMC13467788

The HMG-CoA Reductase Inhibitor Fluvastatin Promotes Th2-Skewed Immune Responses by Modulating Dendritic Cell Differentiation [1]

Research article Ishikawa S, Mizuno H, Murase K, Sasano K, Ogawa I, Itoh Y, et al. · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Statins, inhibitors of HMG-CoA reductase, exert immunomodulatory effects beyond lipid lowering, yet how they regulate T helper (Th) cell differentiation remains poorly understood.
Closing excerpt
These findings indicate that continuous fluvastatin exposure during DC differentiation is associated with an altered DC phenotype and enhanced Th2-polarizing capacity.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (178 words)

Statins, inhibitors of HMG-CoA reductase, exert immunomodulatory effects beyond lipid lowering, yet how they regulate T helper (Th) cell differentiation remains poorly understood. We show that fluvastatin administration to C57BL/6 mice for 7 days suppressed interferon-γ and elevated interleukin-4 production by splenic CD4+ T cells, shifting the immune balance toward Th2 without altering splenocyte numbers or major immune cell subset proportions. This effect was not shared by rosuvastatin, suggesting that lipophilicity-dependent cellular uptake influences immunomodulatory potency. In vitro experiments confirmed a direct Th2-promoting action of fluvastatin on CD4+ T cells. Basophils were excluded as mediating cells, as fluvastatin suppressed rather than enhanced basophil interleukin-4 production. Continuous fluvastatin exposure during granulocyte-macrophage colony-stimulating factor (GM-CSF)-driven dendritic cell (DC) differentiation altered the phenotype of the resulting DCs and markedly enhanced their Th2-polarizing capacity in co-cultures with antigen-specific CD4+ T cells. These functional changes were accompanied by alterations in DC surface molecule expression, although their causal contribution remains to be established. These findings indicate that continuous fluvastatin exposure during DC differentiation is associated with an altered DC phenotype and enhanced Th2-polarizing capacity.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42680200 · DOI · PMC13533597

Palmitate promotes liver metastases by decreasing neutrophil antitumour behaviour [2]

Research article Vandekeere A, Fernández-García J, Peng-Winkler Y, Martín Pérez M, Liu M, Fernandes SI, et al. · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Liver metastases are frequent and challenging to treat owing to the liver's metabolically active and immune-tolerant environment.
Closing excerpt
Taken together, we find that liver palmitate not only supports tumour intrinsic processes but also enables immune evasion.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (150 words)

Liver metastases are frequent and challenging to treat owing to the liver's metabolically active and immune-tolerant environment. However, how cancer cells exploit nutrient availability in the liver to evade immune surveillance remains unknown. Here we show that cancer cells use the palmitate availability in the liver to impair the neutrophil antitumour function. Mechanistically, we find that breast and colorectal cancer cells metastasizing to the liver, but not the lung, require the palmitoyltransferase 17 (DHHC17, gene name ZDHHC17) to stabilize laminin-511 enabling its secretion. In turn, neutrophils in the liver metastasis environment respond to laminin-511 by decreasing their cancer cell-killing capacity. Consistently, silencing ZDHHC17 in cancer cells decreases liver metastases only in the presence of neutrophils, while metastasis growth is restored in ZDHHC17-silenced metastases upon injection of laminin-511 or inhibition of neutrophil degranulation. Taken together, we find that liver palmitate not only supports tumour intrinsic processes but also enables immune evasion.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42557388 · DOI · PMC7619559

Effects of Prepartum Supplementation with Flaxseed and Black Soldier Fly Larvae Oils on Fatty Acid Composition and Lipid Quality Indices in Sheep Milk [3]

Research article Lewandowska K, Pachura-Hanusek N, Szumny A, Zielak-Steciwko A, Kupczyński R · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The peripartum period in prolific ewes is associated with increased metabolic demands, and dietary lipid supplementation may increase the energy density of the prepartum diet.
Closing excerpt
These findings additionally indicate that prepartum lipid supplementation may exert a persistent carry-over effect into early lactation, influencing the fatty acid composition of mature sheep milk.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (217 words)

The peripartum period in prolific ewes is associated with increased metabolic demands, and dietary lipid supplementation may increase the energy density of the prepartum diet. This study evaluated the effects of prepartum supplementation with alternative lipid matrices on the physicochemical characteristics and comprehensive fatty acid (FA) profiles of mature and transitional sheep milk. Thirty-two pregnant Olkuska ewes were randomly assigned to four cohorts (n = 8/group): Control (basal diet), flaxseed oil (low n-3/high n-6 variety; FO), black soldier fly larvae oil (BSFL oil), and Mix oil (2:1 ratio of FO to BSFL oil). Dietary treatments exerted no significant effects (p > 0.05) on transitional milk composition or lipid quality indices. In contrast, in mature milk, BSFL oil supplementation significantly increased milk fat content (6.09%) compared to the Control group (4.70%; p p p cis-9, trans-11 CLA concentration and the significant reduction in both the atherogenic and thrombogenic indices (p < 0.01), were observed exclusively in mature milk. These findings suggest that the combination of sustainable insect lipids with high-linoleic plant oils may represent a viable strategy to transform sheep milk into a functional food with potential cardiovascular health benefits for consumers. These findings additionally indicate that prepartum lipid supplementation may exert a persistent carry-over effect into early lactation, influencing the fatty acid composition of mature sheep milk.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42588476 · DOI · PMC13467788

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce [4]
    Sarris J, Ravindran A, Yatham LN, Marx W, Rucklidge JJ, McIntyre RS, et al. · World J Biol Psychiatry · 2022 · cited 124 times (Europe PMC)
  • Research article The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers [5]
    Wei BZ, Li L, Dong CW, Tan CC, Alzheimer’s Disease Neuroimaging Initiative, Xu W · Am J Clin Nutr · 2023 · cited 119 times (Europe PMC)
  • Research article Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis [6]
    Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM · Circulation · 2021 · cited 113 times (Europe PMC)
  • Research article Effects of Omega-3 Fatty Acids on Muscle Mass, Muscle Strength and Muscle Performance among the Elderly: A Meta-Analysis [7]
    Huang YH, Chiu WC, Hsu YP, Lo YL, Wang YH · Nutrients · 2020 · cited 108 times (Europe PMC)
  • Research article The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis [8]
    Lampl C, MaassenVanDenBrink A, Deligianni CI, Gil-Gouveia R, Jassal T, Sanchez-Del-Rio M, et al. · J Headache Pain · 2023 · cited 104 times (Europe PMC)
  • Research article Impact of α-Linolenic Acid, the Vegetable ω-3 Fatty Acid, on Cardiovascular Disease and Cognition [9]
    Sala-Vila A, Fleming J, Kris-Etherton P, Ros E · Adv Nutr · 2022 · cited 100 times (Europe PMC)

References

  1. Ishikawa S, Mizuno H, Murase K, Sasano K, Ogawa I, Itoh Y, et al.. The HMG-CoA Reductase Inhibitor Fluvastatin Promotes Th2-Skewed Immune Responses by Modulating Dendritic Cell Differentiation. . 2026. PMID 42680200 · DOI · PMC13533597
  2. Vandekeere A, Fernández-García J, Peng-Winkler Y, Martín Pérez M, Liu M, Fernandes SI, et al.. Palmitate promotes liver metastases by decreasing neutrophil antitumour behaviour. . 2026. PMID 42557388 · DOI · PMC7619559
  3. Lewandowska K, Pachura-Hanusek N, Szumny A, Zielak-Steciwko A, Kupczyński R. Effects of Prepartum Supplementation with Flaxseed and Black Soldier Fly Larvae Oils on Fatty Acid Composition and Lipid Quality Indices in Sheep Milk. . 2026. PMID 42588476 · DOI · PMC13467788
  4. Sarris J, Ravindran A, Yatham LN, Marx W, Rucklidge JJ, McIntyre RS, et al.. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World J Biol Psychiatry. 2022. PMID 35311615 · DOI
  5. Wei BZ, Li L, Dong CW, Tan CC, Alzheimer’s Disease Neuroimaging Initiative, Xu W. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers. Am J Clin Nutr. 2023. PMID 37028557 · DOI · PMC10447496
  6. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2021. PMID 34612056 · DOI · PMC9109217
  7. Huang YH, Chiu WC, Hsu YP, Lo YL, Wang YH. Effects of Omega-3 Fatty Acids on Muscle Mass, Muscle Strength and Muscle Performance among the Elderly: A Meta-Analysis. Nutrients. 2020. PMID 33291698 · DOI · PMC7761957
  8. Lampl C, MaassenVanDenBrink A, Deligianni CI, Gil-Gouveia R, Jassal T, Sanchez-Del-Rio M, et al.. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. J Headache Pain. 2023. PMID 37208596 · DOI · PMC10197489
  9. Sala-Vila A, Fleming J, Kris-Etherton P, Ros E. Impact of α-Linolenic Acid, the Vegetable ω-3 Fatty Acid, on Cardiovascular Disease and Cognition. Adv Nutr. 2022. PMID 35170723 · DOI · PMC9526859

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Trans Fatty AcidsDrugs and Chemicals
  • AcetatesDrugs and Chemicals
  • CephalosporinsDrugs and Chemicals
  • Lipid PeroxidesDrugs and Chemicals
  • Cholic AcidDrugs and Chemicals
  • N-Acetylneuraminic AcidDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

535,446
PubMed records on this heading
15%
published since 2020
43,898
review articles
21,062
randomized trials
9
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Trans Fatty AcidsDrugs and Chemicals
  • AcetatesDrugs and Chemicals
  • CephalosporinsDrugs and Chemicals
  • Lipid PeroxidesDrugs and Chemicals
  • Cholic AcidDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support